Inovio plans to start a clinical trial of its coronavirus vaccine in the U.S. next month with the thought to expand to China and South Korea shortly thereafter.Inovio Pharmaceuticals Inc (NASDAQ: INO) is up over 18% in the premarket. Now its price is $8.80. But on Tuesday its results were even more impressive. INO stock gained practically 70%, reaching the level of $7.45. It happened after Inovio announced it has been speeding up the timeline for the development of a vaccine to treat the...
Read More »